New study tests Brain-Focused pain education to ease suffering in breast cancer survivors
NCT ID NCT04730154
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a type of pain education that teaches the brain's role in pain, combined with motivational interviewing, can reduce chronic pain in breast cancer survivors. 156 women who have finished primary treatment and still have pain will be randomly assigned to this new approach or to standard biomedical education. The goal is to see if the new method reduces pain and improves quality of life over 12 to 24 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Pain neuroscience education and motivational interviewing
What this could lead to
If it works, this could offer a non-drug way to reduce chronic pain and opioid use in breast cancer survivors.
What could go wrong
This is a relatively small, early-stage behavioral study. The intervention may not prove superior to standard education, and results may not apply to all survivors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AZ Rivierenland
Bornem, Antwerpen, 2880, Belgium
-
Imeldaziekenhuis
Bonheiden, Vlaams-Brabant, 2820, Belgium
-
Universiteit Hasselt - campus Diepenbeek
Diepenbeek, Limburg, 3590, Belgium
-
Vrije Universiteit Brussel
Jette, Brussels Capital, 1090, Belgium